Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Proposal Gives Tissue Firms Only Two Years To Comply With New Regs

This article was originally published in The Gray Sheet

Executive Summary

Companies that market human tissue-engineered products (hTEP) in the European Union say they are alarmed by a new proposal from the European Commission that will give them only two years to comply with revised premarket regulations
Advertisement

Related Content

European Parliament Approves Revisions To Medical Device Directives
European Parliament Approves Revisions To Medical Device Directives
Regulation For Tissue-Engineered Products Moves Forward In Europe
Regulation For Tissue-Engineered Products Moves Forward In Europe
Advertisement
UsernamePublicRestriction

Register

MT022952

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel